0
Epizyme Inc
- 51-200 Employees
- Based in Cambridge, Massachusetts
Epizyme, Inc., a clinical stage biopharmaceutical company, discovers and develops epigenetic therapies for cancer patients. Its proprietary product platform creates small molecule inhibitors of a 96-member class of enzymes known as histone methyltransferases (HMTs).
Epizyme Inc
Most Recent Annual Report
MOST RECENT
2021 Annual Report and Form 10K
Request Information
Epizyme Inc does not currently have any reports on AnnualReports.com. Click the button below to be notified when financial info becomes available.
